President Trump’s second-term honeymoon is over, but his political resilience is far from exhausted.

Trump is seeking to turn the page after a bleak stretch that saw his approval ratings drop sharply, especially in the wake of his April 2 "Liberation Day" tariffs and the turmoil that ensued.

The situation looked grim around Trump’s 100th day in office on April 30.

Since then, however, he has enjoyed a more favorable stretch.

His pausing of tariffs generally, and the de-escalation of sky-high levies with China in particular, has boosted financial markets.

All three major stock indexes have made up, or surpassed, the levels they enjoyed prior to Trump’s April 2 announcement.

Trump also emphasized his populist instincts with a pledge to get pharmaceutical companies to lower their prices for some prescription drugs.

The idea is that American consumers would pay the same amount for drugs as the residents of other developed nations, rather than paying almost three times as much, as they do now.

There are sizable questions about exactly how this would happen. Trump’s........

© The Hill